Home
About these Guidelines
Acknowledgments
Contents
Feedback
Assessment of the risk
Assessment of the risk of HIV transmission
What is the HIV transmission risk/exposure?
What is the HIV status of the source individual?
What is the HIV status of the exposed individual?
Immediate management and follow-up
Immediate management
Clinical assessment and follow up
Laboratory assessment and follow-up
Prescribing PEP
When to Prescribe PEP
PEP recommendations after occupational exposure
Prescribing PEP
Recommended PEP Regimens
Medications and Cautions
Exposure to other conditions
Hepatitis B
Sexually transmissible infections
Hepatitis C
Pregnancy and breastfeeding
Tetanus
Additional clinical management issues
Preventive behaviours while being managed for HIV exposure
Individuals at risk of HIV acquisition who decline PEP
Individuals at negligible risk of HIV transmission who request PEP
Individuals who re-present for NPEP
Individuals who are on PrEP
Transitioning from PEP to PrEP
Renal disease
Gender identity and history
Individuals who have been sexually assualted
Children
Prisoners and detainees
Individuals who commenced PEP overseas
Risk communication: understanding the risk of exposure
Further information
References
Information for clinicians
Information for patients
Appendix 1: Drugs commonly prescribed in PEP regimens
Post-Exposure Prophylaxis after Non-Occupational Exposure to HIV
Home
Further information
References
Information for clinicians
Information for patients
Appendix 1. Drugs commonly prescribed in PEP regimens
Assessment of the risk
Assessment of the risk of HIV transmission
What is the HIV transmission risk/exposure?
What is the HIV status of the source individual?
What is the HIV status of the exposed individual?
Immediate management and follow-up
Immediate management
Clinical assessment and follow up
Laboratory assessment and follow-up
Prescribing PEP
When to Prescribe PEP
PEP recommendations after occupational exposure
Prescribing PEP
Recommended PEP Regimens
Medications and Cautions
Exposure to other conditions
Hepatitis B
Sexually transmissible infections
Hepatitis C
Pregnancy and breastfeeding
Tetanus
Additional clinical management issues
Preventive behaviours while being managed for HIV exposure
Individuals at risk of HIV acquisition who decline PEP
Individuals at negligible risk of HIV transmission who request PEP
Individuals who re-present for NPEP
Individuals who are on PrEP
Transitioning from PEP to PrEP
Renal disease
Gender identity and history
Individuals who have been sexually assualted
Children
Prisoners and detainees
Individuals who commenced PEP overseas
Risk communication: understanding the risk of exposure
Further information
References
Information for clinicians
Information for patients
Appendix 1: Drugs commonly prescribed in PEP regimens